University of Minnesota. Driven to Discover.
The case prompts a travel advisory and adds to the list of affected countries.
Some topics: weighing risks and benefits, ethical issues, and global involvement.
The next step in the deliberations is a 2-day National Academies of Science symposium in March.
The initial effectiveness investigations flagged a problem with the 2009 H1N1 vaccine virus in the inhaled version and drove improvement efforts.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.